February 28, 2025
February 28, 2024. [NEWS] Company We are proud to announce that we have received the renewal of our Quality Management System Certification based on the international […]
May 3, 2023
May 3, 2023. [NEWS] Company ; METAglut1™ We are pleased to announce that our innovative in vitro diagnostic test, METAglut1™ has been recommended for coverage in […]
April 27, 2023
April 27, 2023. [NEWS] Company ; METAglut1™ We are pleased to announce that the Haute Autorité de Santé (HAS) – the french National Authority for Health […]
April 7, 2022
May 3, 2023. [NEWS] Company ; METAglut1™ We are proud to share insights from Dr. Domitille Gras, a renowned neuropediatrician specializing in speech and learning disabilities […]
September 16, 2021
September 16, 2021. [NEWS] Company Lisses et Paris, 16 septembre 2021. Sebia, leader mondial du diagnostic in vitro (DIV) dans le domaine du myélome multiple et des […]
June 19, 2021
June 19, 2021. [NEWS] Company ; METAglut1™ We were thrilled to attend the 3rd European Conference on GLUT1 Deficiency, which took place virtually, and during which […]
March 22, 2021
March 22, 2021. [NEWS] Company We are proud to announce that we have obtained our Quality Management System Certification based on the international standard NF EN […]
June 12, 2017
June 12, 2023. [NEWS] Company ; METAglut1™ We are pleased to announce that the results of our first study on our innovative in vitro diagnostic test […]
February 15, 2017
February 15, 2017. [NEWS] Company ; METAglut1™ We are proud to announce that the METAglut1™ has been CE marked since February 2017. This significant milestone marks a new […]
